Asterand Bioscience

Asterand is the leading global provider of high quality, well characterized human tissue and human tissue-based research solutions to drug discovery scientists. Our mission is to provide human-based solutions to accelerate the identification and validation of drug targets and enhance the selection of drug candidates with an increased likelihood of clinical success.Asterand has a well established human tissue heritage, having been formed in 2006 through the merger of Asterand (founded 2000), a human tissue biorepository and Pharmagene (founded 1996) a human tissue-based drug discovery company. Our ProductsAsterand Bioscience offers unparalleled access to human tissue through its worldwide network of 75 active collaborative donor institutions. Our XpressBANK™ biobank contains several hundred thousand specimens from a broad range of therapeutic areas and with many ethnicities. Our tissues provide high value to our clients because the quantity of material provided for each sample allows scientists to conduct multiple experiments using a single specimen. In addition, our renowned quality assurance procedures provide stringent controls on specimen collection and characterization and on the corresponding clinical data. As part of this process, we also independently confirm pathology and assess RNA integrity of our tissues. Our quality control results are provided to researchers before they make their purchases. This enables researchers to choose samples that will best meet their scientific requirements. Through our BioSPOKE™ custom procurement service, human tissues and clinical data can also be custom collected to meet special requirements. Our ServicesAsterand Bioscience’s services division offers exemplary scientific expertise in human tissue research, with experience in providing top multinational pharmaceutical companies with human tissue-based services since 1996. Through our PhaseZERO® drug discovery services platform, we provide a collaborative scientific approach to deliver human tissue-based data on target & biomarker validation as well as compound potency, effect and safety. Our studies can be custom designed and are conducted on a fee-for-service basis where our clients own and retain all resulting IP and data.